---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-020776"
form_type: "8-K"
ticker: "AVAH"
cik: "0001832332"
company_name: "Aveanna Healthcare Holdings, Inc."
filed_at: "2023-05-11T23:59:59+00:00"
generated_at: "2026-06-15T04:45:06.998746+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Aveanna Q1 net loss $32M vs prior year net income; revenue up 3.5% to $466.4M

## Summary
- Net loss of $32.0M ($0.17 diluted loss) vs net income of $25.3M ($0.14 diluted EPS) in Q1 2022.
- Adjusted EBITDA fell 25% to $28.5M (6.1% of revenue) from $38.0M (8.4%) in Q1 2022.
- Revenue increased 3.5% to $466.4M, driven by Private Duty Services (+$22.8M) and Medical Solutions (+$3.6M), partially offset by Home Health & Hospice (-$10.5M).
- Company affirms previously issued 2023 guidance; cash of $34.4M and undrawn revolver capacity of $162M as of April 1, 2023.
- Free cash flow was $2.9M for Q1 2023; net cash from operations $7.5M.

## SEC filing metadata
- accession: 0000950170-23-020776
- form_type: 8-K
- ticker: AVAH
- cik: 0001832332
- company_name: Aveanna Healthcare Holdings, Inc.
- filed_at: 2023-05-11T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1832332/000095017023020776/0000950170-23-020776-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1832332/000095017023020776/avah-20230511.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-020776
- JSON: https://secwatch.observer/filing/0000950170-23-020776.json
- Plain text: https://secwatch.observer/filing/0000950170-23-020776.txt

## Key facts
- Earnings Releases
  Aveanna Healthcare Holdings, Inc. reported first quarter 2023 (three-month period ended April 1, 2023) results: revenue $466.4 million, net income -$32.0 million, EPS -$0.17. Guidance reaffirmed.
  - Period: first quarter 2023 (three-month period ended April 1, 2023)
  - Revenue: $466.4 million
  - Net income: -$32.0 million
  - EPS: -$0.17
  - Guidance: reaffirmed
  - Result: reported results
  source text: in this Item 2.02. --- EX-99.1 (EX-99.1) --- EX-99.1 Exhibit 99.1 AVEANNA HEALTHCARE HOLDINGS ANNOUNCES FIRST QUARTER 2023 FINANCIAL RESULTS • Revenue increased 3.5% to $466.4 million, compared to Q1 2022 o Gross margin decreased 0.2% to $144.5 million, compared to Q1 2022 • Net loss was $32.0 million, compared to net income of $25.3 million in Q1 2022 o
  evidence_url: https://www.sec.gov/Archives/edgar/data/1832332/000095017023020776/0000950170-23-020776-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.